These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35006027)

  • 1. Cutaneous ulceration as a presenting feature of type 1 lepra reaction: A case report.
    Hegde P; Jaiswal D; Shetty VM; Pai K; Rao R
    Trop Doct; 2022 Apr; 52(2):354-356. PubMed ID: 35006027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized and persistent erythema nodosum leprosum - a rare variant?
    Prabhu S; Rao R; Sripathi H; Rao L; Singh R
    Dermatol Online J; 2008 Mar; 14(3):16. PubMed ID: 18627717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
    Pal D
    Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lepromatous leprosy in Saudi female from central region.
    al-Majed S
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous erythema nodosum leprosum manifesting in the post partum period with unusual features.
    Verma R; Vasudevan B; Pragasam V; Moorchung N; Mitra D; Gopal M
    Lepr Rev; 2015 Mar; 86(1):96-101. PubMed ID: 26065152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient.
    Suryawati N; Saputra H
    Int J Mycobacteriol; 2018; 7(2):191-194. PubMed ID: 29900900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of recurrent steroid-dependent severe type 2 lepra reaction treated successfully with colchicine.
    Sachdeva S; Sinha S; Sardana K
    Int J Mycobacteriol; 2021; 10(4):472-474. PubMed ID: 34916470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report.
    Kar HK; Raina A; Sharma PK; Bhardwaj M
    Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual non-trophic ulcerations in leprosy: A case series of 17 patients.
    Shukla P; Malhotra KP; Verma P; Suvirya S; Saraswat A; Jain A
    Trop Doct; 2021 Oct; 51(4):542-552. PubMed ID: 33722150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 15. Reactive perforating leprosy, erythema multiforme-like reactions, sweet's syndrome-like reactions as atypical clinical manifestations of Type 2 leprosy reaction.
    Gunawan H; Yogya Y; Hafinah R; Marsella R; Ermawaty D; Suwarsa O
    Int J Mycobacteriol; 2018; 7(1):97-100. PubMed ID: 29516895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
    Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International workshop on erythema nodosum leprosum (ENL)--consensus report; the formation of ENLIST, the ENL international study group.
    Walker SL; Saunderson P; Kahawita IP; Lockwood DN
    Lepr Rev; 2012 Dec; 83(4):396-407. PubMed ID: 23614260
    [No Abstract]   [Full Text] [Related]  

  • 18. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
    Savitha B; Sardana K; Kumari R; Khurana A; Sinha S; Sachdeva S
    Am J Trop Med Hyg; 2021 Oct; 106(1):51-53. PubMed ID: 34662871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare atypical presentations in Type 2 lepra reaction: a case series.
    Vijendran P; Verma R; Vasudevan B; Mitra D; Badad A; Neema S
    Int J Dermatol; 2014 Mar; 53(3):323-6. PubMed ID: 24134145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Necrotizing Erythema Nodosum as a Manifestation of Lepromatous Leprosy Relapse 50 Years after the Initial Infection.
    Galeano J; Contreras A; Pabón L; Ruiz AC; Serrano-Coll H; Arboleda M
    Am J Trop Med Hyg; 2023 Jul; 109(1):53-56. PubMed ID: 37253443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.